Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19 Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04715997
What this trial is testing

Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults

Who this might be right for
SARS-CoV-2
Genexine, Inc. 185
Testing effectiveness (Phase 2)UnknownNCT05124483
What this trial is testing

Anti-COVID19 VaccinaTion AKS-452 BOOSTER (ACT-BOOSTER Study)

Who this might be right for
COVID-19
University Medical Center Groningen 600
Early research (Phase 1)UnknownNCT04982068
What this trial is testing

Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

Who this might be right for
COVID-19
Shanghai Zerun Biotechnology Co.,Ltd 72
Large-scale testing (Phase 3)Study completedNCT05096832
What this trial is testing

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 10,381
Not applicableUnknownNCT04871165
What this trial is testing

Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals

Who this might be right for
Hematologic NeoplasmsCOVID-19 Vaccines
Vilnius University 3,270
Testing effectiveness (Phase 2)Ended earlyNCT04773067
What this trial is testing

Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers

Who this might be right for
COVID-19
United Biomedical Inc., Asia 3,877
Early research (Phase 1)Study completedNCT06147063
What this trial is testing

Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19

Who this might be right for
COVID-19SARS-CoV-2 Infection
AstraZeneca 243
Not applicableUnknownNCT05051605
What this trial is testing

Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation

Who this might be right for
Liver Transplant
Ain Shams University 50
Large-scale testing (Phase 3)WithdrawnNCT05442684
What this trial is testing

Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 Vaccine

Who this might be right for
COVID-19
CanSino Biologics Inc.
Large-scale testing (Phase 3)Study completedNCT05463419
What this trial is testing

A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose.

Who this might be right for
Covid-19 Vaccine
Yisheng Biopharma (Singapore) Pte. Ltd. 5,860
Not applicableStudy completedNCT05489367
What this trial is testing

Does COVİD-19 m-RNA Vaccine Affect Fertility and Over Reserve ?

Who this might be right for
COVID-19 Virus InfectionOvarian Function InsufficiencyFertility Disorders+1 more
Gaziosmanpasa Research and Education Hospital 64
Not applicableUnknownNCT04743947
What this trial is testing

Vaccination Against COVID-19 in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease Stage 5 on DialysisChronic Kidney Disease Stage 5 With TransplantVaccine Response Impaired
Heinrich-Heine University, Duesseldorf 400
Large-scale testing (Phase 3)Study completedNCT05973006
What this trial is testing

Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines

Who this might be right for
COVID-19
Novavax 400
Large-scale testing (Phase 3)Study completedNCT04955626
What this trial is testing

To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 16,372
Post-approval studies (Phase 4)Study completedNCT07089706
What this trial is testing

Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

Who this might be right for
COVID-19
ModernaTX, Inc. 832
Testing effectiveness (Phase 2)Study completedNCT05112848
What this trial is testing

Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19)

Who this might be right for
SARS-CoV-2 Infection
Novavax 384
Testing effectiveness (Phase 2)WithdrawnNCT05029856
What this trial is testing

Evaluation of the Safety and Immunogenicity of SII Vaccine Constructs Based on the SARS-CoV-2 (COVID-19) Variant in Adults

Who this might be right for
Covid19
Novavax
Early research (Phase 1)UnknownNCT04537130
What this trial is testing

Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge

Who this might be right for
Pulmonary FibrosisCovid19
Instituto Oncológico Dr Rosell 40
Not applicableEnded earlyNCT06156228
What this trial is testing

Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos

Who this might be right for
Vaccine Hesitancy
San Diego State University 238
Early research (Phase 1)Study completedNCT04915989
What this trial is testing

Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals

Who this might be right for
SARS-CoV-2
Genexine, Inc. 30
Next Page